Evidence map›Paper›PMID 39568296›Full record

ArticleJournal of labelled compounds & radiopharmaceuticals2024

Towards Optimal Automated

Céleste Souche, Juliette Fouillet, Léa Rubira, Charlotte Donzé, Audrey Sallé, Yann Dromard, Emmanuel Deshayes, Cyril Fersing

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of labelled compounds & radiopharmaceuticals, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. [Pharmaceutics · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Céleste SoucheNuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France.
Juliette FouilletNuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France.
Léa RubiraNuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France.
Charlotte DonzéNuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France.
Audrey SalléNuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France.
Yann DromardInstitut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France.
Emmanuel DeshayesNuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France.
Cyril FersingNuclear Medicine Department, Institut Régional du Cancer de Montpellier (ICM), Université de Montpellier, Montpellier, France.ORCID https://orcid.org/0000-0002-4455-4641

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DOTA-functionalized bisphosphonates can be useful tools for PET imaging of bone metastases when radiolabeled with

Indexed as

Gallium RadioisotopesHeterocyclic Compounds, 1-RingAnimalsAutomationDiphosphonatesIsotope LabelingMiceRadiochemistryRadiopharmaceuticals1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidDiphosphonatesGallium-68Gallium RadioisotopesHeterocyclic Compounds, 1-RingRadiopharmaceuticals

Identifiers

PMID39568296
PMCPMC11641010

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.